Search company, investor...

Predict your next investment

Venture Capital
genoavc.com

See what CB Insights has to offer

Investments

16

Portfolio Exits

1

Funds

4

About Genoa Ventures

Genoa Ventures invests in early-stage companies working in the convergence of biology and technology to solve some of the most fundamental challenges to life. Genoa identifies opportunities early and focuses its investments and expertise to empower the next category-defining companies. The firm was founded in 2018 and is based in San Francisco, California.

Headquarters Location

San Francisco, California, 94110,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Genoa Ventures News

General Inception Creates First-Ever “Igniter” for New Company Formation

Sep 29, 2022

Company emerges from stealth to co-found scientific innovations from inception to growth Download General Inception is creating a new category of company formation. GI is not an accelerator, incubator, or investment fund; it is a company partnering with scientific innovators to bring on the critical planning and execution functions on day one of a new venture, including ignition capital. GI is co-founded by Paul Conley, Ph.D., Vikram Chaudhery, Ph.D., and Jim Buzzitta, M.D., and has raised over $60M from leading venture capital firms Genoa Ventures, Hughes Ventures, Northpond Ventures, OMX Ventures, Paladin Capital Group, and Vertical Venture Partners. GI has partnered with over 25 companies, several of which have already succeeded in attracting quality venture capital financing. General Inception is creating a new category of company formation. GI is not an accelerator, incubator, or investment fund; it is a company partnering with scientific innovators to bring on the critical planning and execution functions on day one of a new venture, including ignition capital. GI is co-founded by Paul Conley, Ph.D., Vikram Chaudhery, Ph.D., and Jim Buzzitta, M.D., and has raised over $60M from leading venture capital firms Genoa Ventures, Hughes Ventures, Northpond Ventures, OMX Ventures, Paladin Capital Group, and Vertical Venture Partners. GI has partnered with over 25 companies, several of which have already succeeded in attracting quality venture capital financing. September 29, 2022 08:01 AM Eastern Daylight Time PALO ALTO, Calif.--( BUSINESS WIRE )-- General Inception (GI), the first-ever Igniter, today announced its launch to build deep-tech companies from their inception through commercial scale-up. GI is not an investment fund; it is a company partnering with scientific innovators to bring on the critical planning and execution functions on day one of a new venture, including ignition capital. With access to a global team of thought leaders and business executives in diverse scientific fields, regulatory, intellectual property, clinical development and manufacturing services, as well as back office and infrastructure support, the GI team industrializes company formation, technology commercialization, and market validation. General Inception comprises a rapidly growing team that already numbers over 50 full-time and fractional executives focused on partnering with scientific innovators who aspire to play an active role in commercializing their innovation but need a complementary co-founder with both technical and business depth. The team brings real-world expertise to company development across a wide range of markets and a first-hand understanding of new product introduction challenges, including regulatory, development, and manufacturing risk. “So many incredible and impactful discoveries do not fully realize their potential due to the complexities of forming and financing at the inception of a company’s life,” said Paul Conley, Ph.D. , co-founder and Chief Executive Officer of General Inception. “After decades of personal experience in company building, I concluded that the craft of starting deep tech companies is different from the craft of investing in them. We believe the ideal approach is to combine the two under one roof while still ensuring that the inventors retain control of their destiny and majority interest in their companies.” Since its founding in 2020, General Inception has raised over $60 million to launch and nurture companies with an initial focus on life science and health tech, but with plans and the team competence to play in every hard science domain in the future. As of today, GI has partnered with over 25 companies, several of which have already succeeded in attracting quality venture capital financing. “As a serial entrepreneur, I have experienced firsthand the huge challenges in taking innovations from the lab through product development and to market,” said Utkan Demirci, Ph.D., co-founder of Mercury Biosciences with GI. Dr. Demirci is also a Stanford University School of Medicine professor and Director of the Canary Center at Stanford for Cancer Early Detection. “General Inception comes in from day one with an experienced team to ensure strategic company inception and development. Their expertise enables rapid scaling and decision making across the board from licensing, product development to market entry.” General Inception is backed by leading venture capital firms Genoa Ventures, Hughes Ventures, Northpond Ventures, OMX Ventures, Paladin Capital Group, and Vertical Venture Partners. GI also has strategic partnerships with contract research, development and manufacturing organizations that facilitate rapid translation of science into products. “General Inception has thought about the challenges of scientific startups and has brought together a team of seasoned executives and experts to work with their co-founders to jump over the initial hurdles of company creation,” said Mike Rubin, M.D., Ph.D., founder and CEO of Northpond Ventures. “We believe General Inception will provide the VC community attractive early-stage investment opportunities with strong foundations for market entry.” About General Inception: General Inception is pioneering company creation as the first Igniter company. As an Igniter, General Inception partners with extraordinary technical founders at the inception of their journey in order to efficiently translate their groundbreaking innovations into transformational businesses that address humanity’s grand challenges. In its role as a co-founder, GI brings together domain expertise, executive talent, infrastructure and development resources, and capital to ignite, nurture and scale throughout the entire company journey. For more information, please visit www.generalinception.com Contacts

Genoa Ventures Investments

16 Investments

Genoa Ventures has made 16 investments. Their latest investment was in Bond Pet Foods as part of their Series A on June 6, 2022.

CBI Logo

Genoa Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/24/2022

Series A

Bond Pet Foods

$17.5M

Yes

3

5/4/2022

Series A

ZwitterCo

$33M

Yes

3

4/7/2022

Series A

Codetta Biosciences

$15M

Yes

3

2/16/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

12/14/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/24/2022

5/4/2022

4/7/2022

2/16/2022

12/14/2021

Round

Series A

Series A

Series A

Series A

Series A

Company

Bond Pet Foods

ZwitterCo

Codetta Biosciences

Subscribe to see more

Subscribe to see more

Amount

$17.5M

$33M

$15M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

3

3

10

10

Genoa Ventures Portfolio Exits

1 Portfolio Exit

Genoa Ventures has 1 portfolio exit. Their latest portfolio exit was Intabio on January 21, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/21/2021

Acquired

$99M

6

Date

1/21/2021

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

6

Genoa Ventures Fund History

4 Fund Histories

Genoa Ventures has 4 funds, including Genoa Ventures Fund II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

7/28/2022

Genoa Ventures Fund II

$84M

2

9/22/2020

Genoa Opportunity SPV II

$99M

10

2/25/2020

Genoa Opportunity SPV I

$99M

10

5/14/2019

Genoa Ventures Fund I

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

7/28/2022

9/22/2020

2/25/2020

5/14/2019

Fund

Genoa Ventures Fund II

Genoa Opportunity SPV II

Genoa Opportunity SPV I

Genoa Ventures Fund I

Fund Type

Subscribe to see more

Status

Subscribe to see more

Amount

$84M

$99M

$99M

$99M

Sources

2

10

10

10

Genoa Ventures Team

1 Team Member

Genoa Ventures has 1 team member, including current Founder, Managing Director, Jenny Rooke.

Name

Work History

Title

Status

Jenny Rooke

Anterra Capital, F-Prime Capital, Bill & Melinda Gates Foundation, Kauffman Fellows, U.S. Genomics, and McKinsey & Company

Founder, Managing Director

Current

Name

Jenny Rooke

Work History

Anterra Capital, F-Prime Capital, Bill & Melinda Gates Foundation, Kauffman Fellows, U.S. Genomics, and McKinsey & Company

Title

Founder, Managing Director

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.